AllPeptides.eu - Advanced Peptide Research
    Research-use-only hub
    2 variants

    Educational protocol hub

    Melanotan I (Afamelanotide): protocol variants and reconstitution resources

    Educational hub for Melanotan I (Afamelanotide), grouping 2 available protocol variants with links to the exact dosage and reconstitution pages.

    What this hub covers

    This page groups the available Melanotan I (Afamelanotide) protocol variants so readers can choose the exact vial-size guide without mixing formats.

    Reconstitution workflow

    Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.

    Research-only context

    All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.

    Available protocol variants

    Choose the exact guide you want to view.

    Melanotan I (Afamelanotide)

    5mg

    Melanotan I (Afamelanotide / [Nle⁴,D-Phe⁷]-α-MSH) is a linear α-MSH analogue, EMA-approved (Scenesse®) for Erythropoietic Protoporphyria (EPP). 5mg vial — reconstitute with 1 mL of bacteriostatic water for 5 mg/mL (10 units = 0.5 mg).

    View protocol

    Melanotan I (Afamelanotide)

    10mg

    Melanotan I (Afamelanotide / [Nle4,D-Phe7]-α-MSH) is a linear α-MSH analog approved in the EU (Scenesse®) for erythropoietic protoporphyria. 10 mg vial.

    View protocol

    Related research resources

    Internal links that help readers and search engines understand this peptide topic cluster.

    References

    1. Langendonk JG et al. N Engl J Med 2015 — Afamelanotide for Erythropoietic Protoporphyria.
      View Source
    2. EMA — Scenesse EPAR — European assessment of Scenesse (afamelanotide)
      View Source

    Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.

    Educational Navigator

    Educational reading navigator

    Find where to start in research peptide science through evidence, safety context and regulatory awareness.

    Covers

    Evidence levelsSafety contextRegulatory overviewLiterature readingResearch methodEducational reports
    5 min readEvidence-firstOpen access
    Open evidence framework

    New knowledge, new tools and selected updates from AllPeptides.eu